Proteasome inhibitor bortezomib-induced apoptosis in natural killer (NK)-cell leukemia and lymphoma: an in vitro and in vivo preclinical evaluation

Blood. 2007 Jul 1;110(1):469-70. doi: 10.1182/blood-2007-02-072900.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects
  • Boronic Acids / therapeutic use*
  • Bortezomib
  • Cell Line, Tumor
  • Drug Screening Assays, Antitumor
  • Humans
  • Killer Cells, Natural / drug effects
  • Killer Cells, Natural / pathology*
  • Leukemia, T-Cell / drug therapy*
  • Leukemia, T-Cell / pathology
  • Lymphoma, T-Cell / drug therapy*
  • Lymphoma, T-Cell / pathology
  • Protease Inhibitors / therapeutic use
  • Pyrazines / therapeutic use*
  • Tumor Cells, Cultured

Substances

  • Boronic Acids
  • Protease Inhibitors
  • Pyrazines
  • Bortezomib